FDA panel backs much-debated ALS drug in rare, 2nd review

A panel of federal health advisers voted Wednesday to recommend approval for an experimental drug to treat Lou Gehrig’s disease, a remarkable turnaround for the much-debated medication that was previously rejected by the same group.


Read More

Previous post UK school chaplain sues after being fired, reported as terrorist for sermon questioning LGBTQ activists
Next post GOP accuses Biden of requesting new round of nearly $12B in Ukraine aid to benefit Democrats ahead of midterms